Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Consultants and Independent Financial Advisors	Employees	Preferred Stock	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Consultants and Independent Financial Advisors	Additional Paid-In Capital Employees	Accumulated Deficit	Noncontrolling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative effect of adoption of ASC 606 (See Note 2)	$ 24,785								$ 24,774	$ 11
Beginning Balance	395,176			$ 2	$ 20	$ 520,135			(125,004)	23
Beginning Balance (in shares) at Dec. 31, 2017				17,012,075	198,583,941
Beginning Balance at Dec. 31, 2017	370,391			$ 2	$ 20	520,135			(149,778)	12
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock purchase plan (in shares)					59,944
Issuance of common stock under employee stock purchase plan	186					186
Exercise of stock options (in shares)					553,599
Exercise of stock options	828					828
Stock-based compensation		$ 7	$ 1,487				$ 7	$ 1,487
Issuance of restricted stock (in shares)					1,855,000
Issuance of restricted stock	0
Repurchase and retirement of common stock (in shares)					(534,697)
Repurchase and retirement of common stock	(1,729)					(1,729)
Preferred stock issued, net of underwriting discount and expense	(37)					(37)
Preferred stock dividends declared and paid	(8,508)					(8,508)
Common stock dividends declared and paid	(1,960)					(1,960)
Net income	5,464								5,463	1
Ending Balance (in shares) at Mar. 31, 2018				17,012,075.000	200,517,787.000
Ending Balance at Mar. 31, 2018	390,914			$ 2	$ 20	510,409			(119,541)	24
Beginning Balance (in shares) at Dec. 31, 2018				17,012,075	146,535,796
Beginning Balance at Dec. 31, 2018	253,177			$ 2	$ 14	344,356			(91,246)	51
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock purchase plan (in shares)					57,104
Issuance of common stock under employee stock purchase plan	154					154
Exercise of stock options (in shares)					170,217
Exercise of stock options	285				$ 0	285
Stock-based compensation		$ 11	$ 1,483				$ 11	$ 1,483
Issuance of restricted stock (in shares)					2,325,000
Issuance of restricted stock	1				$ 1
Repurchase and retirement of common stock (in shares)					(341,704)
Repurchase and retirement of common stock	(1,052)					(1,052)
Preferred stock issued, net of underwriting discount and expense (in shares)				287,230
Preferred stock issued, net of underwriting discount and expense	6,915					6,915
Preferred stock dividends declared and paid	(8,590)					(8,590)
Common stock dividends declared and paid	(1,794)					(1,794)
Net income	3,432								3,431	1
Ending Balance (in shares) at Mar. 31, 2019				17,299,305.000	148,746,413.000
Ending Balance at Mar. 31, 2019	$ 254,022			$ 2	$ 15	$ 341,768			$ (87,815)	$ 52